美诺华(603538.SH)：子公司获得枸橼酸莫沙必利片药品注册证书

Core Viewpoint - Meinuohua (603538.SH) announced that its wholly-owned subsidiary, Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd., has received the drug registration certificate for Mosapride Citrate Tablets from the National Medical Products Administration, indicating a significant regulatory approval for the company’s product [1] Group 1 - The drug is indicated for improving gastrointestinal symptoms caused by decreased gastrointestinal motility, such as functional dyspepsia and chronic gastritis [1] - Symptoms addressed by the drug include heartburn, belching, nausea, vomiting, early satiety, upper abdominal bloating, and upper abdominal pain [1]